Within our model, the rule associated with the lowest probability of being treated (0.21) is the one including females without a diagnosis of AD (node 4); while the one with the highest probability of being treated (0.63) is that which includes males diagnosed with AD or dementia and who have an APOE ε4 genotype (node 31). This evidence concerns the gene APOE and dementia.